enGene Holdings Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation Canada (Federal Level)
Business Address 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, A8, H4R 2P1
Mailing Address 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, A8, H4R 2P1
Phone (514) 332-4888
Fiscal Year End 1031
EIN 000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 27, 2026 | View on SEC |
| 8-K Current report of material events | January 21, 2026 | View on SEC |
Annual Reports
10-K December 22, 2025
- The company transitioned its CEO in February 2024, signaling potential new strategic directions.
- enGene completed private placements in February and October 2024 and announced a public offering for November 2025.
Related Companies
Companies in the same industry (SIC: 2836)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
CRISPR Therapeutics AG
CRSP Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.